SAM #75N98026Q00991

NIH Solicitation: PRISM Drug Sensitivity Study for Compound NCGC01219867

The National Institutes of Health (NIH), Office of the Director, Office of Logistics and Acquisition Operations, is seeking a contractor to conduct a specialized drug sensitivity study for a pharmacological compound. - Government Buyer: - National Institutes of Health (NIH), Office of the Director, Office of Logistics and Acquisition Operations - Service Requested: - PRISM study of compound NCGC01219867 - Broad Institute pooled cancer cell line drug sensitivity assay - Testing against approximately 900 barcoded cancer cell lines - 5-day assay using Luminex-format screens at 8-point dose with 3-fold dilution - Contractor to provide all services, personnel, materials, equipment, and facilities - Deliverables: cell viability data, assay quality metrics, feature set correlation analysis, and raw data via PRISM Portal - Unique/Notable Requirements: - The government will supply the compound analog for screening - Data must be delivered through the PRISM Portal - Study must use the Broad Institute's pooled cancer cell line platform - No specific OEMs or commercial product manufacturers are named, but the Broad Institute's technology is central to the requirement

Description

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes only solicitation; proposals are being requested, and a separate written solicitation will not be issued.(ii) The solicitation number is 75N98026Q00991. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold (if applicable).The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a (Firm-Fixed-Price) to the offeror responsible whose proposal represents the best value to the Government.(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular effective August 7, 2026(iv) The associated NAICS code is 325412 Pharmaceutical Preparation Manufacturing and the small business size standard is 1300 employees.This requirement is unrestricted.

View original listing